Le Lézard
Classified in: Health
Subject: STP

Pennsylvania Department of Health and Department of Environmental Protection Report First Human Case of West Nile Virus in Pennsylvania in 2017


HARRISBURG, Pa., Aug. 8, 2017 /PRNewswire-USNewswire/ -- Pennsylvania's first probable human case of West Nile Virus (WNV) infection in 2017 has been detected in a Montgomery County resident. The Departments of Health and Environmental Protection strongly recommend that all residents minimize their exposure to mosquitoes.

"Detecting the first human case of West Nile Virus this year serves as a great reminder for Pennsylvanians to take the proper precautions when they are outside or near areas where mosquitoes are prevalent," Acting Secretary of Health and Physician General Dr. Rachel Levine said. "There are some simple steps you can take to protect yourself and your loved ones from mosquito-related diseases."

Although mosquitoes can bite at any time of the day or night, the mosquitoes that transmit WNV are most active at dawn and dusk. When outdoors, people can avoid mosquito bites by properly and consistently using DEET-containing insect repellants and covering exposed skin with lightweight clothing. To keep mosquitoes from entering a home, make sure window and door screens are in place and are in good condition.

The Department of Environmental Protection (DEP) conducts regular surveillance and control to manage mosquito populations around the state. So far, DEP has detected WNV-infected mosquitoes in 36 counties.

"DEP monitors the mosquito population across Pennsylvania," said Secretary Patrick McDonnell. "Today's announcement serves as a reminder that all Pennsylvanians should take precautions to protect against mosquitoes. Using a personal insect repellant or staying indoors during dawn and dusk will help prevent exposure to mosquitoes."

The mosquitoes that transmit WNV breed in areas with standing and stagnant water. These areas can include urban catch basins, clogged gutters, discarded tires, poorly maintained swimming pools, flower pots and other types of plastic containers.

Simple steps to eliminate standing water around the home include:

DEP will continue to survey affected communities to monitor mosquito activity and WNV. DEP biologists have initiated a survey of the mosquito population to determine the risk for further human illness. If necessary, adult mosquito populations will be reduced. These efforts will continue through October.

For a fact sheet on WNV, including symptoms, please click on the Department of Health's West Nile Virus Fact Sheet.

For more information, including current WNV test results for mosquitoes, birds and horses, visit http://www.westnile.state.pa.us/ and click on Surveillance Maps and Tables, or call 1-877-PA HEALTH.

For more information on West Nile Virus, visit www.health.pa.gov or follow us on Facebook and Twitter.

MEDIA CONTACT: April Hutcheson, 717-787-1783 or [email protected]
Neil Shader, DEP, 717-787-1323

SOURCE Pennsylvania Department of Health


These press releases may also interest you

at 04:35
A team of researchers led by Associate Professor Alfredo Franco-Obregón from the NUS Institute for Health Innovation & Technology (iHealthtech) has unveiled a novel approach to stimulate muscle, by way of using brief and mild pulsed electromagnetic...

at 04:05
PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the next generation of drug targets, today announced the introduction of GlueSEEKERtm. The new phenotypic screening platform expands the Company's capabilities in this emerging...

at 04:03
The National Comprehensive Cancer Network® (NCCN®)?a global nonprofit responsible for leading cancer treatment guidelines?is taking part in two events in Warsaw focused on advancing...

at 03:52
The 10th European Stroke Organization Congress (ESOC), held in Basel, Switzerland from May 15 to 17, 2024, showcased six studies on Sanbexin® (Edaravone and Dexborneol Concentrated Solution for Injection) and a new dosage form of sublingual tablets...

at 03:12
GC Biopharma (006280. KS) and Novel Pharma have announced that the U.S. FDA has cleared the investigational new drug (IND) application for their jointly developed MPSIIIA (Sanfilippo Syndrome Type A) treatment, GC1130A....

at 03:05
PathAI, a global leader in AI-powered pathology, today announced a new Early Access Program (EAP) to drive adoption of its AISightTM Image Management System (IMS) in Mainland Europe.1 Earlier in 2023, PathAI announced a similar program for...



News published on and distributed by: